Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.57 |
| ▸ | FNTA | P49354 | 2/20 | 0.49 |
| ▸ | FNTB | P49356 | 2/20 | 0.49 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6567588 | 1.00 | ALDH1A1 (0.63) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL6021942 | 0.90 | ALDH1A1 (0.76) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL22833273 | 0.90 | ALDH1A1 (0.76) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL31171145 | 0.90 | ALDH1A1 (0.76) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL31171136 | 0.90 | ALDH1A1 (0.76) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL27735904 | 0.89 | ALDH1A1 (0.73) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL14273812 | 0.89 | ALDH1A1 (0.73) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL6743833 | 0.89 | ALDH1A1 (0.73) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL7907073 | 0.88 | KDM4E (0.52) | ALDH1A1ALOX15FNTAFNTB | |
| SCHEMBL7907074 | 0.88 | KDM4E (0.52) | ALDH1A1ALOX15FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0887336-B1 | Precursor compounds | GIVAUDAN SA (CH) | 2004-01-07 | — | — | EP | claimed |
| US-6207857-B1 | FOR ORGANOLEPTIC AND ANTIMICROBIAL COMPOUNDS GENERATED IN THE PRESENCE OF SKIN BACTERIA, ENZYMES OR ACIDIC OR ALKALINE CONDITIONS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 2001-03-27 | — | — | US | claimed |
| EP-0887336-B1 | Precursor compounds | GIVAUDAN SA (CH) | 2004-01-07 | — | — | EP | disclosed |
| US-6207857-B1 | FOR ORGANOLEPTIC AND ANTIMICROBIAL COMPOUNDS GENERATED IN THE PRESENCE OF SKIN BACTERIA, ENZYMES OR ACIDIC OR ALKALINE CONDITIONS | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 2001-03-27 | — | — | US | disclosed |
| EP-0887336-A1 | Precursor Compounds | GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) | 1998-12-30 | — | — | EP | disclosed |